Although the mechanism by which the NR3C1 Bcl1 G allele might be involved in the prevalence of dyslipidemia is not clear, the analysis of dyslipidemia-related polymorphisms may provide a means to predict patient's risk for having dyslipidemia. The gene discussed is CCND1; the disease is metabolic syndrome.